FDA Regulatory Insights & Compliance Guides

A mailbox or answering service can't be your U.S. FDA Agent (21 CFR 1.227, 207.69). What an active, physically present Agent does, and the red flags to check.

A U.S. Agent appointment is not an FDA facility registration. See which filing your food, drug, device or cosmetic facility needs first in 2026.

How to register your facility and list your sunscreen with the FDA — establishment registration, NDC, and SPL submission, step by step.

If you're a foreign sunscreen manufacturer registering with the FDA, you need a U.S. Agent. Here's what they do and why it matters.

A step-by-step U.S. compliance roadmap for foreign sunscreen manufacturers using bemotrizinol — registration, listing, labeling, U.S. Agent, and the timeline.

Foreign manufacturers exporting drugs, dietary supplements, or medical devices to the USA are legally required to appoint a U.S. FDA Agent. Discover who needs one, what they do, and how to choose the right agent to protect your market access in 2026.

Navigating the regulatory landscape for pharmaceutical, nutraceutical, cosmetics, and biotech products requires precise compliance steps. One critical element in this process is understanding the role of the DUNS number and facility registration. These identifiers are essential for companies aiming to enter and operate within the US market, especially when dealing with the US Food and Drug Administration (FDA). This post breaks down what these registrations mean, who needs th

Entering the US market is a massive opportunity for pharmaceutical, nutraceutical, and biotech manufacturers. However, the path to market access is guarded by one of the world's most stringent regulators: The FDA. For foreign manufacturers, compliance isn't just about filling out a form—it’s about survival. A single error in your establishment registration or a missed communication from your US Agent can lead to Import Alerts, detained shipments, and costly delays. This guide

Pharmaceutical, OTC, dietary supplement, and cosmetic companies face increasing pressure to treat FDA compliance as a central business concern rather than a back-office task. Regulatory missteps can cause serious setbacks such as drug listing inactivation, import alerts, retail delisting, delayed launches, and reputational harm. For mid-to-large brands preparing U.S. market entries or portfolio expansions, compliance is now a strategic priority that requires close collaborati

Navigating the regulatory landscape of the US Food and Drug Administration (FDA) is essential for pharmaceutical, nutraceutical, and biotech manufacturers aiming to enter or expand in the US market. Understanding the requirements and processes involved in FDA compliance services can save time, reduce risks, and accelerate product approval. This guide provides a clear, practical overview of the key aspects of FDA compliance, helping you confidently manage your regulatory oblig

Global manufacturers face significant challenges when exporting pharmaceutical and nutraceutical products to the United States. The U.S. Food and Drug Administration (FDA) enforces strict import regulations to ensure product safety and regulatory compliance. Yet, many import delays and refusals arise not from product quality but from avoidable documentation and procedural errors. Understanding these common pitfalls and implementing preventive measures can save time, reduce co

Understanding the FDA Registration Process Entering the U.S. market requires careful planning. The FDA registration process is not just a formality; it is a critical step that can make or break your market entry strategy. The Importance of Preparation Preparation is key. The first 30 days are crucial. During this time, you must ensure that all necessary documentation is in order and that your understanding of FDA requirements is clear. This preparation can significantly impac